altogether better

Integrated research compliance solutions to streamline your study

Get a Quote

75% of US-Based Operation Warp Speed  Vaccine Trials Overseen by Advarra IRB, IBC

Webinar: October 27

Racial Diversity in Clinical Trials: Building Trust in Participant Engagement

Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.

Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.

Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more

Our Latest Updates

Discover What’s Happening at Advarra

Advarra Joins #NoGoingBack Movement to Preserve Recent Progress in Clinical Research

October 15, 2020

Signant Health recently initiated the #NoGoingBack movement, recognizing that COVID-19 forced the clinical research community to move trial conduct forward rapidly. This movement focuses on keeping in place the clinical…

Oct271 pm ET

Racial Diversity in Clinical Trials: Building Trust in Participant Engagement

COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions…


Q&A – The Must-Haves of FDA and Common Rule Reporting Requirements

October 14, 2020

In a recent webinar, Advarra regulatory experts discussed the must-haves of FDA and Common Rule reporting requirements. They reviewed the basics of what must be reported to whom—and when—for sponsors…

Ready for Research Compliance Solutions That Are Altogether Better?

Get Started